Daniëlle Heideman

Dr. Daniëlle Heideman is a Senior Clinical Scientist in Molecular Pathology at the University of Groningen's Faculty of Medical Sciences. Her work focuses on molecular pathology, biomarker development, and HPV-related research. She holds roles in multiple organizations including chairmanship of the Dutch Society of Pathology's IVDR working group and advisory board membership at Self-screen B.V., where she is a co-founder and minority shareholder. Her research emphasizes cervical cancer screening, HPV genotyping, and biomarker validation for clinical management.

Her expertise spans clinical diagnostics, molecular epidemiology, and translational research. She collaborates internationally on projects involving HPV prevalence studies, assay validation, and post-vaccination risk assessment. Key contributions include advancing self-sampling techniques and refining triage strategies for cervical lesions. Her work bridges laboratory science with clinical practice, aiming to improve early detection and management of oncogenic infections.

Dr. Heideman's professional network includes advisory roles in regulatory and diagnostic sectors (e.g., DEKRA expert for IVDR), ensuring her research aligns with real-world clinical needs. Grants and collaborations underpin her projects, though specific funding details are not listed here. Her lab activities focus on molecular diagnostics and biomarker validation with a global health perspective.